Over the last 10 years, generic drugs have saved the U.S. healthcare system about $1.68 trillion. 2016 was a record-setting year for FDA’s generic drug program.
Year 2016 was a mixed year for the pharma industry with increasing number of acquisitions and mergers, foreign investments, layoffs, regulatory hurdles and new challenges. Biospectrum takes a look at the top Mergers and Acquisitions in 2016